Naciye Mulayim

Summary

Publications

  1. ncbi request reprint Vulvar basal cell carcinoma: two unusual presentations and review of the literature
    Naciye Mulayim
    Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    Gynecol Oncol 85:532-7. 2002
  2. ncbi request reprint Chemoradiation with 5-fluorouracil and mitomycin C in the treatment of vulvar squamous cell carcinoma
    Naciye Mulayim
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, CT 06520, USA
    Gynecol Oncol 93:659-66. 2004
  3. ncbi request reprint Borderline smooth muscle tumors of the uterus
    Naciye Mulayim
    Department of Obstetrics and Gynecology, Anadolu Health Center, Gebze, Kocaeli, Turkey
    Obstet Gynecol Clin North Am 33:171-81. 2006

Detail Information

Publications3

  1. ncbi request reprint Vulvar basal cell carcinoma: two unusual presentations and review of the literature
    Naciye Mulayim
    Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    Gynecol Oncol 85:532-7. 2002
    ..In general, vulvar BCCs tend to grow at slow rates. Nonetheless, they may be locally invasive and destructive if they are neglected. Eight cases of vulvar BCC metastatic to regional lymph nodes have been documented in the literature...
  2. ncbi request reprint Chemoradiation with 5-fluorouracil and mitomycin C in the treatment of vulvar squamous cell carcinoma
    Naciye Mulayim
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, CT 06520, USA
    Gynecol Oncol 93:659-66. 2004
    ..To investigate the acute and late toxicities associated with the use of chemoradiation therapy (CRT) with 5-fluorouracil (5-FU) and mitomycin C or mitomycin C alone for primary, adjuvant, and salvage therapy for vulvar cancer...
  3. ncbi request reprint Borderline smooth muscle tumors of the uterus
    Naciye Mulayim
    Department of Obstetrics and Gynecology, Anadolu Health Center, Gebze, Kocaeli, Turkey
    Obstet Gynecol Clin North Am 33:171-81. 2006
    ..The authors believe that in future, as the number of cases with intermediate clinical outcome and morphologic features increases, and as molecular markers of prognosis are studied, managing these tumors will become more objective...